RecruitingGlaucoma and Ocular Hypertension

Clarifying the Optimal Application of SLT Therapy Trial

Eligible age

18+ yrs

Accepts

All genders

Locations

16 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.

Sponsor: University of Pittsburgh

You may qualify if…

✓ 1. Age 18 or older and in good health
✓ 2. Each eye with one of the following qualifying diagnoses (diagnoses may differ between eyes):
✓ 1. High-risk ocular hypertension (OHT): IOP \> 21 mmHg without glaucomatous optic neuropathy (excavation, diffuse or focal thinning or notching of the neuroretinal rim, visible nerve fiber layer defects, or asymmetry of the vertical cup-to-disc ratio of \>0.2 between eyes)
✓ 2. Mild primary open-angle glaucoma: glaucomatous optic neuropathy, visual field mean deviation better than -6.0 dB with no points in the central 5° \<15 dB (see figure on next page)
✓ 3. Moderate primary open-angle glaucoma: glaucomatous optic neuropathy, visual field mean deviation equal to or worse than -6.0 dB but no worse than -12.0 dB and no central 5° points \<15 dB or mean deviation -12.0 dB or better with 1 central 5° points \<15 dB (see figure on next page).
✓ 3. Each eye with BCVA 20/200 (UK 6/60) or better

You may not qualify if…

✕ 1. Use of topical IOP-lowering medications for more than 6 cumulative months at any time in the past 5 years (this is a modification implemented during active enrollment)
✕ 2. Any history of IOP-lowering laser (prophylactic iridotomy not included) or surgical procedure
✕ 3. Advanced POAG in either eye (worse than moderate POAG as defined above)
✕ 4. Glaucoma other than POAG (including pigmentary and pseudoexfoliation glaucoma) in either eye
✕ 5. Mean IOP \> 35 mmHg at either the screening or baseline visit in either eye
✕ 6. Narrow or closed angle (Shaffer Grade 0, 1, or 2) in either eye
✕ 7. Contraindications to SLT or any other study intervention
✕ 8. Any corneal pathology that would preclude accurate assessment of IOP by Goldmann tonometry in either eye